Showing results (261-270 of 472) with videos related to
Sort By:
Pageof 48
Expert Opinion on Pharmacotherapy|January 15, 2024
Effectiveness and safety of oral terbinafine for dermatophyte distal subungual onychomycosisAditya K Gupta, Shruthi Polla Ravi, Mesbah Talukder, et al.Skinmed|September 17, 2024
OpzeluraTM (Ruxolitinib) Cream 1.5William Abramovits, Akhil Abraham, Kimberly Dawn Vincent, et al.Journal of Cosmetic Dermatology|June 30, 2023
The relative effect of monotherapy with 5-alpha reductase inhibitors and minoxidil for female pattern hair loss: A network meta-analysis studyAditya K Gupta, Tong Wang, Mary A Bamimore, et al.Physiology and Molecular Biology of Plants : an International Journal of Functional Plant Biology|May 10, 2021
Overexpression of SlHSP90.2 leads to altered root biomass and architecture in tomato (Solanum lycopersicum)Pawan K Yadav, Nisha Gupta, Vivek Verma, et al.Dermatologic Clinics|September 6, 2003
Treatments of tinea pedisAditya K Gupta, Melody Chow, C Ralph Daniel, et al.Journal of Cosmetic Dermatology|December 2, 2024
Therapeutic Potential of Extracellular Vesicles (Exosomes) Derived From Platelet-Rich Plasma: A Literature ReviewAditya K Gupta, Tong Wang, Jeffrey A Rapaport, et al.Medical Mycology|February 13, 2009
In vitro pharmacodynamic characteristics of griseofulvin against dermatophyte isolates of Trichophyton tonsurans from tinea capitis patientsAditya K Gupta, Judith V Williams, Muhammad Zaman, et al.Skinmed|November 9, 2023
ZORYVETM (Roflumilast) Cream: A Topical Phosphodiesterase-4 Inhibitor for the Treatment of PsoriasisAditya K Gupta, Shruthi Polla Ravi, Kimberly Vincent, et al.Dermatologic Therapy|May 18, 2020
Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosisAditya K Gupta, Maanasa Venkataraman, Neil H Shear, et al.The Journal of Dermatological Treatment|January 12, 2026
Oral finasteride use and sexual adverse events: signal detection from disproportionality analyses of data from the United States Food and Drug Administration Adverse Event Reporting SystemAditya K Gupta, Mesbah Talukder, Greg Williams, et al.Pageof 48